• Over 235 mln COVID-19 vaccine doses administered across China

    Nearly 235.98 million doses of COVID-19 vaccines had been administered across China as of Tuesday, the National Health Commission said Wednesday.

  • Over 3.3 mn lives lost due to COVID this year, 2022 must be year we end pandemic: WHO chief

    Noting that over 3.3 million people have lost their lives to COVID-19 this year - more deaths than from HIV, malaria and tuberculosis combined in 2020 -- WHO has said that "2022 must be the year we end the pandemic".

  • Over 359 million COVID-19 vaccine doses administered worldwide

    At least 132 countries and territories have administered more than 359 million doses of Covid-19 vaccines so far.

    As per the data provided by Our World In Data cited by The New York Times, 359,460,397 doses have been administered and as many as 4.7 persons have been vaccinated per 100 people.
    In the US, as many as 135,847,835 doses have been delivered and 109,081,860 doses have been administered.

  • Over 500 relics found in prehistoric Sanxingdui Ruins in SW China

    Over 500 artifacts were unearthed in the six ancient sacrificial pits newly discovered in Sanxingdui Ruins in southwest China’s Sichuan Province between November 2019 and May 2020, including pieces of gold masks, bird-shaped gold pieces, and pieces of miniature ivory sculptures, said archaeologists during a meeting held in Chengdu, capital of Sichuan on March 20.

    The historic site, located in Sichuan's Guanghan, is believed to be the remnants of the ancient Shu Kingdom dating back some 3,000 years to 5,000 years ago. It is hailed as one of the greatest archaeological findings in the 20th century. Discussions on it have never faded since the first two sacrificial pits were discovered in 1986.

  • Oxford-AstraZeneca vaccine developers claim that it reduces COVID-19 transmission

    As per a report by developers of the Oxford-AstraZeneca coronavirus vaccine on Sunday, claimed that it can reduce the transmission of COVID-19 virus, reported The Washington Post.

    In a preprint of an article under review at the Lancet medical journal, the Oxford University vaccine developers report that was based on follow-up studies of their clinical trials found the vaccine safe and effective, there is also "the potential for the vaccine to reduce transmission of the virus".

  • Pandemic depression persists among older adults: Study

    The COVID-19 pandemic has had a significant impact on the mental health of older people living in the community, with those who are lonely faring far worse, according to new research from McMaster University.

  • PD Editorial: A hundred years of glory created, an eternal cause to build

    The past century has witnessed many hardships and achievements. At this important moment when the new journey of building a modern socialist country in an all-round way starts smoothly, we usher in the 100th anniversary of the Communist Party of China (CPC). Standing at this critical historical juncture, looking back at the past winding road, overlooking the road ahead of struggles, we are full of excitement, passion and pride.

  • Pfizer CEO predicts COVID-19 vaccine booster to be effective for 1 year

    Pfizer CEO Albert Bourla said on Tuesday that he predicts the COVID-19 vaccine booster shots will be effective for a year, but warned that more research needs to be done to assess their effectiveness.

  • Pfizer says its COVID-19 oral antiviral candidate reduces risk of hospitalisation by 89pc

    American pharmaceutical company Pfizer announced on Friday that its investigational COVID-19 oral antiviral candidate, Paxlovid, showed an 89 percent reduction in hospitalisation or lethal cases in high-risk patients.

  • Pfizer, BioNTech begin testing of third dose against new COVID-19 variants

    Pfizer and its partner BioNTech on Thursday said that they have begun to test how well the third dose of their authorised vaccine stacks up against new coronavirus variants.

    The study will evaluate up to 144 Phase 1 participants in two age cohorts, 18-55 and 65-85 years of age.

  • Pfizer, BioNTech not sure on vaccines' effectiveness on new COVID variant 'Omicron'

    The pharmaceutical companies Pfizer and BioNTech on Saturday issued a statement stating that they are not sure whether their vaccines would be able to help in the treatment of the new COVID-19 variant 'Omicron'.

  • Pfizer's oral drug to stop COVID-19 could be ready next year, says CEO

    Pfizer CEO Albert Bourla has said that an oral drug for treating coronavirus could be ready next year adding the company is working on two antivirals, an oral and an injectable.

    "We are actually on two, one is injectable and the other one an oral (antiviral)...

  • Pirates: Commission must rethink vision on COVID-19 vaccine passport

    The Commission’s plan to introduce a “Digital Green Pass” for EU citizens threatens fundamental rights in several respects. While the European Pirates in the Greens/EFA Group support measures that aim at restoring the freedom of movement, they need to be proportionate.

  • Practices to form cliques, follow bloc politics will never succeed

    The Group of Seven (G7) recently wrapped up a summit and issued a joint communique in which it made irresponsible and false statements on issues related to China’s Xinjiang, Hong Kong and Taiwan, viciously slandered China, and interfered in China’s domestic affairs.

    Such act runs counter to the purposes and principles of the UN Charter and the trend of the times of peace, development and win-win cooperation. It exposes the bad intentions of the United States and a few other countries to deliberately create antagonism and widen differences.

  • Quotable Quotes: Xi Jinping on national heroes, martyrs

    The 4th of April this year marks the Qingming Festival, an important day on the lunar calendar when Chinese people traditionally sweep the tombs of their deceased family members and pay tributes to their ancestors.

    During this day, Chinese people also pay respect to martyrs.

  • Rapid antigen tests less sensitive for detecting Omicron variant infections: US Food and Drug Administration

    The Food and Drug Administration in the US has said that rapid antigen tests are less sensitive for detecting Omicron variant infections.

    "Early data suggest that antigen tests do detect the omicron variant but may have reduced sensitivity," FDA said in a statement on Tuesday (local time).

  • Research develops rapid test to identify effectiveness of antibodies against Covid-19 variants

    Biomedical engineers of Duke University have developed a test to quickly and easily assess how well a person's neutralizing antibodies fight multiple variants of COVID-19 like Delta and the new Omicron variant.

  • Research explores how immune system gets altered by COVID-19

    Ludwig Maximilian University of Munich researchers say that COVID-19 reduces the numbers and functional competence of certain types of immune cells in the blood.

    This could affect responses to secondary infections. The findings were published in the journal PLOS Pathogens.

  • Research finds COVID-19 testing kits also measure oral microbiome in saliva

    A new research by Rutgers University has found that the COVID-19 saliva testing kits that include a novel preservative can also be used to measure microscopic organisms in the mouth. This has enabled the study of the relationship between mouth and lung microbes and the SARS-CoV-2 virus that can develop new treatments.

  • Researchers create new test to quickly identify COVID-19 infection and severity

    The first, second and now third wave has made one thing amply clear: the speed of getting the results of the COVID-19 test plays an important role in its diagnosis and treatment. Now, researchers from George Washington (GW) University have made a breakthrough discovery.